Adherence to GLP-1s better than earlier reported Source: Marshall, LZ et al Trends in 1-year persistence and adherence among initiators of high-potency, weight lossindicated glucagon-like peptide 1 receptor agonists, J Man Care Pharm February 27, 2026 Multiple studies have reported low adherence to GLP-1 medications to treat obesity, and some have cited this as a reason why employers should not cover these medications
Get the Bundle Nutritional Support System Free Mixer with Purchase 20% Off + FREE Shipping Every 30 Days No Commitments Skip, Pause or Cancel Anytime 30-Day, Money-Back Guarantee Buy Now What is Replenza
Feel free to take the list, try it out, keep what works for you, and ditch what doesnt
With the implementation of patient-focused drug development program, improvement in quality of life based on patient self-reporting is also being used as one of the criteria for assessing the anti-fibrotic effects of drugs (Harvey, 2022)